Table 2.
Top 12 DEMs between AR patients and controls in microarray
| DEMs | LogFC | AveExpr | P Value | Trend |
|---|---|---|---|---|
| miR-1908-5p | 2.708755 | 4.308389 | 1.17E-11 | UP |
| miR-126-5p | 3.21136 | 4.562552 | 4.90E-11 | UP |
| miR-92a-3p | 2.266234 | 3.53371 | 3.07E-08 | UP |
| miR-572 | -1.20753 | 1.494931 | 4.18E-06 | DOWN |
| miR-1228-3p | -0.91754 | 1.178168 | 4.28E-06 | DOWN |
| miR-483-5p | -0.9257 | 1.357245 | 1.11E-05 | DOWN |
| miR-125a-5p | 2.177425 | 3.772401 | 1.84E-05 | UP |
| miR-19a-5p | 1.039185 | 1.351904 | 0.000276 | UP |
| miR-26a-5p | 1.032444 | 1.02019 | 0.000417 | UP |
| miR-106a-5p | 1.477438 | 2.025603 | 0.000566 | UP |
| miR-181c-3p | 0.992658 | 0.714471 | 0.000582 | UP |
| miR-3177-3p | 0.723816 | 0.699096 | 0.00067 | UP |
Top 12 DEMs were selected according to P value. Comparison was determined by limma package in R software. AR, allergic rhinitis; DEMs, differentially expressed miRNAs; LogFC, log2 (fold change); AveExpr, average of expression level; Trend: UP, Up-regulated; Down, Down-regulated.